Evaluates the efficacy of ablative CO2 laser for xanthelasma in adults, suggesting it is effective and safe.
Objectives:The objective of the study is to evaluate the efficacy and safety of ablative carbon dioxide (CO 2 ) laser in the treatment of xanthelasma palpebrarum.Methods: This interventional study included 90 patients aged 18-65 years with grade I-III xanthelasma.Patients with grade IV lesions and significant comorbidities were excluded.Baseline clinical and biochemical evaluation was performed.Lesions were treated with ablative CO 2 laser using standardized parameters (60-90 mJ energy, 210 Hz frequency).Patients were followed up monthly for 3 months.Efficacy was assessed using five-point scale score and patient satisfaction score.Results: Most patients were females (85.6%) and belonged to the 25-45-year age group (54.4%).Upper eyelid involvement was predominant (97.8%).Progressive improvement in lesion clearance was observed with > 75% clearance achieved in 56.7% patients at 3 months (p = 0.001).At the end of the study, 72.2% patients were very satisfied.Common adverse effects included erythema, edema, and scabbing.Hypopigmentation was the most frequent complication (65.6%), while recurrence occurred in 5.6% cases.Conclusion: Ablative CO 2 laser is a safe and effective treatment modality for xanthelasma palpebrarum, offering good cosmetic outcomes with high patient satisfaction and low recurrence rates.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: